Published on 01 January 2022

A Phase III, Prospective, Multicentre, Open Label, Extension Study, to Assess the Long Term Safety and Efficacy of Repeated Treatment of Dysport® Intramuscular Injection in the Treatment of Lower Limb Spasticity in Adult Subjects With Spastic Hemiparesis Due to Stroke or Traumatic Brain Injury

Ipsen

Description

The purpose of this research study is to assess the long term safety of Dysport® in hemiparetic subjects with lower limb spasticity due to stroke or traumatic brain injury over repeated treatment cycles.

Citations (0)

No citations found

It looks like this dataset has no citations.

Mentions (0)

No mentions found

It looks like this dataset has not been mentioned in any sources.

Metrics

Dataset Index

1.0

FAIR Score

46%

Citations

Mentions

Metrics Over Time

Publication Details

DOI

10.25934/pr00008365

Publisher

Vivli

Assigned Domain

Subfield

Epidemiology

Field

Medicine

Domain

Health Sciences

Confidence Score

60%

Source

Scholar Data Model

Keywords

Conditions: Post-stroke SpasticityConditions: Spasticity Post-Traumatic Brain InjuryInterventions: Botulinum toxin type A

Normalization Factors

15.38

CTw

1.00

MTw

1.00